Literature DB >> 9690379

Analysis of signaling protein kinases in human colon or colorectal carcinomas.

L L Licato1, D A Brenner.   

Abstract

Extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein (MAP) kinases are highly activated in an in vivo rat model of colorectal carcinogenesis. In addition, other protein kinases such as c-Src and c-Yes have been shown to be up-regulated in some human colon cancers. To evaluate the activity of these kinases in human colorectal carcinomas, we examined colon cancers and adjacent normal intestinal mucosa from 11 patients. Moderate increases in ERK and JNK activities, in addition to up-regulation of c-Src, p125FAK, and tyrosine-phosphorylated proteins, were observed in a subset of the colorectal carcinomas. There was a significant correlation found between levels of c-Src, p125FAK, and tyrosine-phosphorylated proteins, as well as between c-Src protein levels and JNK activity. This is the first report that examines several different kinases as markers to characterize colorectal cancers in the same carcinoma sample, allowing the determination of correlations between markers in the same tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690379     DOI: 10.1023/a:1018894227169

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  50 in total

1.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.

Authors:  T Smeal; B Binetruy; D Mercola; A Grover-Bardwick; G Heidecker; U R Rapp; M Karin
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

2.  Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes.

Authors:  C A Cartwright; S Mamajiwalla; S A Skolnick; W Eckhart; D R Burgess
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

3.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 4.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

5.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia.

Authors:  L L Licato; T O Keku; J I Wurzelmann; S C Murray; J T Woosley; R S Sandler; D A Brenner
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

8.  The jun and fos protein families are both required for cell cycle progression in fibroblasts.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun.

Authors:  E Cano; C A Hazzalin; L C Mahadevan
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

10.  Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

View more
  12 in total

1.  KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.

Authors:  Jen Jen Yeh; Elizabeth D Routh; Tara Rubinas; Janie Peacock; Timothy D Martin; Xiang Jun Shen; Robert S Sandler; Hong Jin Kim; Temitope O Keku; Channing J Der
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

2.  MAP kinase genes and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Roger K Wolff
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

3.  Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.

Authors:  Han-Mo Koo; Matt VanBrocklin; Mary Jane McWilliams; Stephan H Leppla; Nicholas S Duesbery; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

5.  Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.

Authors:  Géraldine Ibarz; Catherine Oiry; Eric Carnazzi; Philippe Crespy; Chantal Escrieut; Daniel Fourmy; Jean Claude Galleyrand; Didier Gagne; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 6.  Arachidonic acid and colorectal carcinogenesis.

Authors:  Raymond Jones; Luis-Alfonso Adel-Alvarez; Osvaldo Rascon Alvarez; Russell Broaddus; Siddhartha Das
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.

Authors:  Kunihiro Hosono; Eiji Yamada; Hiroki Endo; Hirokazu Takahashi; Masahiko Inamori; Yoshitaka Hippo; Hitoshi Nakagama; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 8.  Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways.

Authors:  Qiang Shen; Powel H Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

9.  Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.

Authors:  Koga Komatsu; F Gregory Buchanan; Michiro Otaka; Mario Jin; Masaru Odashima; Yohei Horikawa; Sumio Watanabe; Raymond N Dubois
Journal:  Mol Cancer       Date:  2006-11-17       Impact factor: 27.401

10.  p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism.

Authors:  Adrian W O'Sullivan; Jiang H Wang; Henry P Redmond
Journal:  World J Surg Oncol       Date:  2009-11-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.